[Clinical case: perioperative chemotherapy of gastric cancer: for whom? which risks?]
- PMID: 19345537
- DOI: 10.1016/j.gcb.2009.02.012
[Clinical case: perioperative chemotherapy of gastric cancer: for whom? which risks?]
Similar articles
-
Peroperative hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer.Eur J Surg Oncol. 2000 Sep;26(6):630-2. doi: 10.1053/ejso.2000.0964. Eur J Surg Oncol. 2000. PMID: 11034822 No abstract available.
-
Perioperative chemotherapy for gastric cancer: how should we measure the efficacy?Ann Surg Oncol. 2009 Apr;16(4):1077-9. doi: 10.1245/s10434-008-0310-7. Epub 2009 Jan 24. Ann Surg Oncol. 2009. PMID: 19169756 No abstract available.
-
Perioperative chemotherapy for gastric cancer.Ann Surg Oncol. 2009 Jan;16(1):226-7. doi: 10.1245/s10434-008-0117-6. Epub 2008 Sep 5. Ann Surg Oncol. 2009. PMID: 18773245 No abstract available.
-
Treatment of resectable gastric cancer: current standards of care.Expert Rev Anticancer Ther. 2009 Jan;9(1):135-42. doi: 10.1586/14737140.9.1.135. Expert Rev Anticancer Ther. 2009. PMID: 19105713 Review.
-
A review of adjuvant therapy for resected primary gastric cancer with an update on Taegu's phase III trial with intraperitoneal chemotherapy.Eur J Surg Oncol. 2006 Aug;32(6):655-60. doi: 10.1016/j.ejso.2006.03.010. Epub 2006 Apr 18. Eur J Surg Oncol. 2006. PMID: 16618532 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical